Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Complix N.V.
DescriptionBispecific Alphabody-antibody fusion protein targeting tumor necrosis factor (TNF) alpha and interleukin-23 (IL-23)
Molecular Target Tumor necrosis factor (TNF) alpha ; Interleukin-23 (IL-23)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Fusion protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today